9 trends tracked about this subject — the full history, oldest to newest below.
GSK anticipates its oncology clinical pipeline will nearly double in 2027 following an aggressive period of dealmaking and strategic acquisitions.
Incyte presents new early clinical data at ESMO for its KRAS G12D-targeted pancreatic and colorectal cancer medicine.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Roche's new lung-cancer drug divarasib shows superior survival rates compared to rivals in late-stage trials, targeting the emerging oncology market.
AstraZeneca is showcasing a new portfolio of targeted cancer therapies, featuring a stomach cancer drug that significantly extended patient survival times.
Amgen reports that combining Imdelltra with Imfinzi reduces the risk of death by 58% for patients with first-line extensive stage small cell lung cancer.
Moderna's cancer vaccine shows a 42% reduction in melanoma recurrence in Phase 3 trial data leaked prior to ESMO.
Moderna shares surge and track toward top September S&P 500 performance as markets eye upcoming clinical data.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.